GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » PensionAndRetirementBenefit

LTR Pharma (ASX:LTP) PensionAndRetirementBenefit : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma PensionAndRetirementBenefit?

LTR Pharma's PensionAndRetirementBenefit for the quarter that ended in Dec. 2024 was A$0.00 Mil.


LTR Pharma PensionAndRetirementBenefit Historical Data

The historical data trend for LTR Pharma's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma PensionAndRetirementBenefit Chart

LTR Pharma Annual Data
Trend Jun24
PensionAndRetirementBenefit
-

LTR Pharma Semi-Annual Data
Dec23 Jun24 Dec24
PensionAndRetirementBenefit - - -

LTR Pharma PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


LTR Pharma Business Description

Industry
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.

LTR Pharma Headlines

No Headlines